Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-25-111760
Filing Date
2025-11-18
Accepted
2025-11-18 06:44:14
Documents
19
Period of Report
2026-01-08

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT ea0263416-03.htm   iXBRL DEF 14A 1319771
2 GRAPHIC tjoycemason_sig.jpg GRAPHIC 30168
3 GRAPHIC tproxy_001.jpg GRAPHIC 1095230
4 GRAPHIC tproxy_002.jpg GRAPHIC 1324524
5 GRAPHIC tproxy_003.jpg GRAPHIC 1143035
  Complete submission text file 0001213900-25-111760.txt   10582487

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE rfl-20251118.xsd EX-101.SCH 9892
7 XBRL DEFINITION FILE rfl-20251118_def.xml EX-101.DEF 2763
8 XBRL LABEL FILE rfl-20251118_lab.xml EX-101.LAB 34739
9 XBRL PRESENTATION FILE rfl-20251118_pre.xml EX-101.PRE 5450
21 EXTRACTED XBRL INSTANCE DOCUMENT ea0263416-03_htm.xml XML 247879
Mailing Address 520 BROAD STREET NEWARK NJ 07120
Business Address 520 BROAD STREET NEWARK NJ 07120 212-658-1450
Rafael Holdings, Inc. (Filer) CIK: 0001713863 (see all company filings)

EIN.: 822296593 | State of Incorp.: DE | Fiscal Year End: 0731
Type: DEF 14A | Act: 34 | File No.: 001-38411 | Film No.: 251492768
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)